1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics
(
- Contribution to journal › Article
- 2018
-
Mark
Quantitative analysis of phantom studies of 111In and 68Ga imaging of neuroendocrine tumours
(
- Contribution to journal › Article
- 2016
-
Mark
Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide ¹⁷⁷Lu Compared to Alpha Particles and Gamma Rays
(
- Contribution to journal › Article
-
Mark
Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2
(
- Contribution to journal › Article
- 2014
-
Mark
188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors : preclinical assessment
2014) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 55(11). p.8-1842(
- Contribution to journal › Article
- 2011
-
Mark
Monte Carlo calculations of absorbed doses in tumours using a modified MOBY mouse phantom for pre-clinical dosimetry studies.
(
- Contribution to journal › Article
- 2007
-
Mark
Mouse S-factors based on monte carlo simulations in the anatomical realistic Moby phantom for internal dosimetry
(
- Contribution to journal › Article
- 2005
-
Mark
Dosimetry Calculations on a Tissue Level by Using the MCNP4c2 Monte Carlo Code.
(
- Contribution to journal › Article